leisure time -WSS

leisure time

author：hotspot 2025-09-30 22:41:24 - browse：43

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： When waiting feels immoral: Empathy in the emergency department

entertainment

WSS

Pharma showers House GOP doctor with campaign cash

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

Flagship, Pfizer team up in deal worth up to $7 billion

Heart disease in astronauts blamed on cosmic radiation

entertainment

leisure time

entertainment

In age of alternative facts, a scholarly course on calling out crap

2 officers injured in shooting in Orlando, police say

Guidelines to prevent youth baseball injuries need more muscle

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Psychedelics group wrestles with new pharma identity

Alnylam reports growth in sales of rare disease treatments

Hepatitis C has a cure — but many Americans still lack access to it

Johnson & Johnson sues to stop Medicare negotiation

State Dept. review finds Biden bears some blame for Afghanistan failures

Group behind ProMed defends move to subscription

leisure time

Pharma showers House GOP doctor with campaign cash

How I helped Pfizer think through the ethics of Viagra

FDA scientists endorse Pfizer/BioNTech Covid

When waiting feels immoral: Empathy in the emergency department

FDA approves Sage Therapeutics’ rapid

CDC recommends RSV monoclonal antibody for infants

entertainment

focus

explore

focus